Benzothiazole and azabenzothiazole compounds useful as...

Details Benzothiazole and azabenzothiazole compounds useful as... Benzothiazole and azabenzothiazole compounds useful as...

2011-08-09

2011-08-09

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S367000

Reexamination Certificate

active

07994337

ABSTRACT:
A compound of Formula (I)an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from:further wherein R1, R2, R3, R4, R5, R6, R7, and W are as described herein.

REFERENCES:
patent: 4200750 (1980-04-01), Warner, Jr. et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5712279 (1998-01-01), Biller et al.
patent: 5739135 (1998-04-01), Biller et al.
patent: 5760246 (1998-06-01), Biller et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 6087496 (2000-07-01), Anantanarayan et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6184231 (2001-02-01), Hewawasam et al.
patent: 6251914 (2001-06-01), Adams et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6548529 (2003-04-01), Robl et al.
patent: 6706720 (2004-03-01), Atwal et al.
patent: 2004/0039033 (2004-02-01), Atwal et al.
patent: WO97/25045 (1997-07-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO01/01986 (2001-01-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO2004/014900 (2004-02-01), None
Das et al., “Discovery of 2-Amino-heteroaryl-benzothiazole-6-anilides as Potent p56lckInhibitors”, Biorganic and Medicinal Chemistry Letters, vol. 13, pp. 2587-2590, 2003.
Database Accession No. 2004:150106 abstract, Chemical Abstracts Service, Columbus, Ohio, El-Sharief et al., “1,4-Phenylenediisothiocyanate in the synthesis of bis(thiourea, benzothiazole, quinazoline, 1,3-benzoxazine, and imidazolidiniminothiones) derivatives”, XP00002414255 retrieved from STN, Phosphorus, Sulfur and the Related Elements, 179 (2), 267-275, 2004.
Database Accession No. 1997:255643 abstract, Chemical Abstracts Service, Columbus, Ohio, Ambat et al., “A facile synthesis of 2-(methylamino)-benzothiazoles”, XP002414256 retrieved from STN, Synthetic Communications, 27 (9), 1487-1493, 1997.
Garin et al., “Synthesis of Unsymmetrical Diheteroarylbenzenes: Benzazole and Quinazoline Derivatives”, Journal of Heterocyclic Chemistry, vol. 28, No. 2, 359-363, 1991.
Database Accession No. 1991:23845 abstract, Chemical Abstracts Service, Columbus, Ohio, Shirke et al., “Synthesis and antitubercular activity of some new 2-(substituted arylamino)-5,6-disubstituted/6-substituted benzothiazoles”, XP002414257 retrieved from STN, Indian Drugs, 27 (6), 350-353, 1990.
Database Accession No. 1983:539834 abstract, Chemical Abstracts Service, Columbus, Ohio, Pande et al., “Synthesis of 2-arylaminobenzothiazoles and aryl isothiocyanates as antitubercular agents”, XP002414258 retrieved from STN, Indian Journal of Chemistry, Section B, Organic Chemistry Including Medicinal Chemistry, 22B (3), 311-312, 1983.
Database Accession No. 1978:170021 abstract, Chemical Abstracts Service, Columbus, Ohio, Vinkler et al., “The formation of 1,3-benzothiazole derivatives from 2,2′-diaminodiphenyl disulfide. Sulfocyanation of 2,2′-diaminodiphenyl sulfide and its reaction with N-aryl isothiocyanates”, XP002414259 retrieved from STN, ACTA Chimica Academiae Scientiarum Hungaricae, 94 (4), 357-361, 1977.
Ahn, S., et al., “Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity”, J. Med. Chem., vol. 40, pp. 2196-2210, (1997).
Greene, T. W., “Protective Groups in Organic Synthesis”, 2ndEdition, John Wiley & Sons, Inc., New York, Table of Contents, (1991).
Henry, J. R., et al., “p38 mitogen-activated protein kinase as a target for drug discovery”, Drugs of the Future, vol. 24(12), pp. 1345-1354, (1999).
Moreland, L. W., et al., “Etanercept Therapy in Rheumatoid Arthritis”, Ann. Intern. Med., vol. 130, pp. 478-486, (1999).
Raingeaud, J., et al., “MKK3- and MKK6-Regulated Gene Expression is Mediated by the p38 Mitogen-Activated Protein Kinase Signal Transduction Pathway”, Molecular and Cellular Biology, vol. 16(3), pp. 1247-1255, (1996).
Rankin, E. C. C., et al., “The Therapeutic Effects of an Engineered human Anti-Tumour Necrosis Factor Alpha Antibody (CDP571) in Rheumatoid Arthritis”, British Journal of Rheumatology, vol. 34, pp. 334-342, (1995).
Salituro, F. G., et al., “Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases”, Current Medicinal Chemistry, vol. 6, pp. 807-823, (1999).

Affiliated with

Also associated with

Rating

Benzothiazole and azabenzothiazole compounds useful as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzothiazole and azabenzothiazole compounds useful as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazole and azabenzothiazole compounds useful as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2752291